Agilent Early Career Professor Award Presented to Carl DeSelm
October 14 2020 - 8:00AM
Business Wire
Washington University School of Medicine in St. Louis professor
recognized for research in cellular immunotherapy
Agilent Technologies Inc. (NYSE: A) today announced that Carl
DeSelm, M.D., Ph.D., has received the 2020 Agilent Early Career
Professor Award. Dr. DeSelm is an assistant professor of Radiation
Oncology at the Washington University School of Medicine in St.
Louis, MO. This years’ award topic is cellular engineering and
analysis—a field that greatly impacts Agilent customers.
The DeSelm lab’s current research focuses on the engineering and
clinical development of a new class of cell immunotherapy,
engineering Antigen Presenting Cells (APC). This approach can
address some of the limitations of the CAR T cell therapy in the
treatment of solid tumors. There is also interest in understanding
and leveraging the role that radiation treatment can have to
synergize with CAR-APC immunotherapy.
"Carl is an outstanding young investigator, and we are thrilled
for him to receive this prestigious award,” said Julie Schwarz, MD,
Ph.D., professor and vice-chair of research in Washington
University’s Department of Radiation Oncology. “Support from the
Agilent Early Career Professor Award will allow Carl to grow and
further develop his research program and explore new exciting
applications of CAR cell engineering."
“Advances in cellular immunotherapy rely on the engineering
(genome editing) and characterization of cell populations and the
quality control of cells during large-scale amplification and
delivery,” explained Jack Wenstrand, Ph.D., director of University
Relations and External Research at Agilent. “By partnering with a
leading young researcher in this important field, we continue our
investment to support the development of better cell therapeutics
products and solutions.”
Wenstrand stated that Dr. DeSelm was selected as the 2020
recipient because of his exceptional early-career contributions,
strong publications, and compelling research plans in the field of
cellular immunotherapy. Dr. DeSelm joined the Washington University
faculty in June 2018 as an assistant professor of Radiation
Oncology. His laboratory is part of the Bursky Center for Human
Immunotherapy and Immunology Programs (CHiiPs), and he is a Bursky
fellow at the School of Medicine. Dr. DeSelm earned his M.D. and
Ph.D. from Washington University School of Medicine in 2012.
The Agilent Early Career Professor Award is an annual program
that recognizes–and supports–promising research from professors
who, early in their careers, show outstanding potential for future
research in areas of importance to the communities Agilent serves.
This award underscores Agilent's commitment to furthering research
through the company's products and services, financial support, and
collaborative engagement by Agilent scientists and engineers.
Further information about the Agilent Early Career Professor Award
is available at Agilent.com.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in life
sciences, diagnostics, and applied chemical markets. In its 20th
year as an independent company delivering insight and innovation
toward improving the quality of life, Agilent instruments,
software, services, solutions, and people provide trusted answers
to customers' most challenging questions. The company generated
revenue of $5.16 billion in fiscal 2019 and employs 16,300 people
worldwide. Information about Agilent is available at
www.agilent.com. To receive the latest Agilent news, subscribe to
the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and
Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201014005151/en/
Media Contact Naomi Goumillout Agilent Technologies
+1.781.266.2819 naomi.goumillout@agilent.com
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Mar 2024 to Apr 2024
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Apr 2023 to Apr 2024